These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 6185524)

  • 21. Somatomedin levels in the diagnosis and therapy of growth hormone deficiency.
    Giannella-Neto D; Wajchenberg BL; Mendonca BB; Liberman B; Nery M; Macchione M; Spencer EM
    Horm Metab Res; 1988 Mar; 20(3):175-81. PubMed ID: 3384400
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effect of growth hormone treatment on somatomedin levels in growth hormone-deficient children.
    Dean HJ; Kellett JG; Bala RM; Guyda HJ; Bhaumick B; Posner BI; Friesen HG
    J Clin Endocrinol Metab; 1982 Dec; 55(6):1167-73. PubMed ID: 6752166
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Circulating levels and molecular distribution of the acid-labile (alpha) subunit of the high molecular weight insulin-like growth factor-binding protein complex.
    Baxter RC
    J Clin Endocrinol Metab; 1990 May; 70(5):1347-53. PubMed ID: 1692332
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Influence of parasitism on plasma concentrations of growth hormone, somatomedin-C and somatomedin-binding proteins in calves.
    Elsasser TH; Rumsey TS; Hammond AC; Fayer R
    J Endocrinol; 1988 Feb; 116(2):191-200. PubMed ID: 2450946
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Diagnostic markers of permanent idiopathic growth hormone deficiency.
    Adan L; Souberbielle JC; Brauner R
    J Clin Endocrinol Metab; 1994 Feb; 78(2):353-8. PubMed ID: 7508948
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Stimulation of growth hormone (GH) and somatomedin C in idiopathic GH-deficient subjects by intermittent pulsatile administration of synthetic human pancreatic tumor GH-releasing factor.
    Borges JL; Blizzard RM; Evans WS; Furlanetto R; Rogol AD; Kaiser DL; Rivier J; Vale W; Thorner MO
    J Clin Endocrinol Metab; 1984 Jul; 59(1):1-6. PubMed ID: 6427267
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Structure, specificity, and regulation of the insulin-like growth factor-binding proteins in adult rat serum.
    Yang YW; Wang JF; Orlowski CC; Nissley SP; Rechler MM
    Endocrinology; 1989 Sep; 125(3):1540-55. PubMed ID: 2547590
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunoassay of a somatomedin-binding protein from human amniotic fluid: levels in fetal, neonatal, and adult sera.
    Drop SL; Kortleve DJ; Guyda HJ; Posner BI
    J Clin Endocrinol Metab; 1984 Nov; 59(5):908-15. PubMed ID: 6207200
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Radioimmunoassay of a 26,000-dalton plasma insulin-like growth factor-binding protein: control by nutritional variables.
    Busby WH; Snyder DK; Clemmons DR
    J Clin Endocrinol Metab; 1988 Dec; 67(6):1225-30. PubMed ID: 2461386
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical features and endocrine status in patients with growth hormone insensitivity (Laron syndrome).
    Savage MO; Blum WF; Ranke MB; Postel-Vinay MC; Cotterill AM; Hall K; Chatelain PG; Preece MA; Rosenfeld RG
    J Clin Endocrinol Metab; 1993 Dec; 77(6):1465-71. PubMed ID: 7505286
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Different effects of intermittent and continuous growth hormone (GH) administration on serum somatomedin-C/insulin-like growth factor I and liver GH receptors in hypophysectomized rats.
    Maiter D; Underwood LE; Maes M; Davenport ML; Ketelslegers JM
    Endocrinology; 1988 Aug; 123(2):1053-9. PubMed ID: 3396497
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expression of serum insulin-like growth factors, insulin-like growth factor-binding proteins, and the growth hormone-binding protein in heterozygote relatives of Ecuadorian growth hormone receptor deficient patients.
    Fielder PJ; Guevara-Aguirre J; Rosenbloom AL; Carlsson L; Hintz RL; Rosenfeld RG
    J Clin Endocrinol Metab; 1992 Apr; 74(4):743-50. PubMed ID: 1372321
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Radioimmunoassay of a basic somatomedin: comparison of various assay techniques and somatomedin levels in various sera.
    Bala RM; Bhaumick B
    J Clin Endocrinol Metab; 1979 Nov; 49(5):770-7. PubMed ID: 39945
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Characterization of the acid-labile subunit of the growth hormone-dependent insulin-like growth factor binding protein complex.
    Baxter RC
    J Clin Endocrinol Metab; 1988 Aug; 67(2):265-72. PubMed ID: 2455727
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effect of growth hormone treatment on the insulin-like growth factor axis in a child with nonislet cell tumor hypoglycemia.
    Katz LE; Liu F; Baker B; Agus MS; Nunn SE; Hintz RL; Cohen P
    J Clin Endocrinol Metab; 1996 Mar; 81(3):1141-6. PubMed ID: 8772589
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Kinetics of the somatomedin C/insulin-like growth factor I: response to exogenous growth hormone (GH) in GH-deficient children.
    Blethen SL; Daughaday WH; Weldon VV
    J Clin Endocrinol Metab; 1982 May; 54(5):986-90. PubMed ID: 7037825
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Quantitation of urinary somatomedin-C in children with normal and abnormal growth.
    Quattrin T; Albini CH; Vandlen RL; MacGillivray MH
    J Clin Endocrinol Metab; 1987 Dec; 65(6):1168-71. PubMed ID: 3680479
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The measurement of insulin-like growth factor I: clinical applications and significance.
    Teale JD; Marks V
    Ann Clin Biochem; 1986 Jul; 23 ( Pt 4)():413-24. PubMed ID: 3094423
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Circulating forms of insulin-like growth factor-I(IGF-I)/somatomedin C (SMC) in fetal life: relationship between changes in its binding proteins and growth delay during intrauterine and post-natal periods].
    Yamasaki A; Morikawa H; Ueda Y; Mochizuki M
    Nihon Naibunpi Gakkai Zasshi; 1989 Mar; 65(3):137-51. PubMed ID: 2475369
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Administration of growth hormone (GH), but not insulin-like growth factor-I (IGF-I), by continuous infusion can induce the formation of the 150-kilodalton IGF-binding protein-3 complex in GH-deficient rats.
    Gargosky SE; Tapanainen P; Rosenfeld RG
    Endocrinology; 1994 May; 134(5):2267-76. PubMed ID: 7512499
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.